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Abstract
Silver nanoparticles supported on nanoscale silicate platelets (AgNP/NSP) possess interesting properties, including a large
surface area and high biocide effectiveness. The nanohybrid of AgNP/NSP at a weight ratio 7/93 contains 5-nm Ag particles
supported on the surface of platelets with dimensions of approximately 8068061n m
3. The nanohybrid expresses a trend of
lower cytotoxicity at the concentration of 8.75 ppm Ag and low genotoxicity. Compared with conventional silver ions and
the organically dispersed AgNPs, the nanohybrid promotes wound healing. We investigated overall wound healing by using
acute burn and excision wound healing models. Tests on both infected wound models of mice were compared among the
AgNP/NSP, polymer-dispersed AgNPs, the commercially available Aquacel, and silver sulfadiazine. The AgNP/NSP
nanohybrid was superior for wound appearance, but had similar wound healing rates, vascular endothelial growth factor
(VEGF)-A levels and transforming growth factor (TGF)-b1 expressions to Aquacel and silver sulfadiazine.
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Introduction
Currently, silver-ion compounds, such as silver sulfadiazine (SS)
cream, are applied to burn wounds to promote healing because of
their antibacterial and pro-healing effects. [1,2] Anti-bacterial
activity is an important factor for wound healing. Re-epithelization
occurs during wound healing and involves the proliferation of
keratinocytes and the differentiation of fibroblasts. [3] Keratino-
cyte proliferation generates an epidermal-skin layer, and the
fibroblasts create the contractile force during wound healing. [4]
Recent developments in nanotechnology for synthesizing nano-
meter-size materials may provide an opportunity for enabling
effective wound healing due to material surface interaction with
cells and tissue. [5] In general, silver compounds are utilized as
therapeutic modalities for wound management due to their
biocidal activities toward a wide spectrum of microorganisms
and their anti-inflammatory effects. [6–10] By contrast, the silver-
ion compounds may have cytotoxic effects and impair the wound
healing process. [11] Furthermore, the material stability and
efficacy for wound healing could be tailored by nanotechnology
such as controlling the size of the silver nanoparticles.
The properties of nanomaterials that are 1–100 nm in size can
be manipulated [12,13] to affect their functions when interacting
with biomaterials and biomedicines. [14,15] Among the various
types of nanomaterials, the clay minerals are ubiquitous in soils
and considered to be safe materials for utilization in medical
applications. Specifically, montmorillonite clay comprised of
primary stack units of multiple aluminosilicate sheets with average
dimension of approximately 80 nm680 nm61 nm were modified
into high?surface?area silicate platelets. [16,17] Individual platelets
possessing high surface charges and surface area are suitable for
supporting inorganic nanoparticles such as silver nanoparticles
(AgNPs). The properties of the resultant material regarding its size
compatibility, geometricshape, and complementary and synthetic
feasibility are important considerations when developing a new
nanomaterial. Previously, we have found that nanohybrids of
AgNPs tethered to silicate clays with a multilayered stack primary
structure could be effective in inhibiting a broad spectrum of
bacteria. [18] However, the nanohybrids have a general inherent
tendency for aggregation into bulk and reduction of the efficacy.
The syntheses of new species of nanometer-scaled inorganic
materials without aggregation remain a challenge. [19] Our
earlier development of the exfoliation technique for preparing
nanoscale silicate platelets (NSP) [16,17,20] could provide a new
material with a high surface area to interact with AgNPs. The Ag
immobilized on silicate platelets (AgNP/NSP) was found to possess
interesting properties, such as a high surface area and biocidal
activity. [21] The goal of this study was to examine the
performance of the nanohybrid in the wound healingprocess. In
vitro assays were performed, including cytotoxicity and genotoxi-
city tests, to confirm the safety profile and to determine the
adequate concentration. Then, mice were used as an in vivo model
to examine the efficacy of AgNP/NSPs in a mouse skin wound
healing tests. The potential of AgNP/NSPs to regulate the levels of
cytokines related to angiogenesis, fibrosis, and wound inflamma-
tion were also evaluated.
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Comparison of the Cytotoxicity and Genotoxicity of
AgNP/NSP, Poly-Ag, and Commercial Silver-ion Drugs
Compared with the six layers of stacked clay in our previous
report, single-layered NSPs are fully exfoliated and their ionic
charges are exposed on the surface. These characteristics enable
the formation of smaller AgNPs (7 nm vs. 26 nm diameters) and
provide a larger cell-material contact surface, possibly accounting
for the improved antibacterial effectiveness of this new nanohybrid
[21]. The cytotoxicity of AgNP/NSPs to human foreskin fibroblast
(Hs68) cells was determined with the MTT assay [20], indicating
a dose-dependent cytotoxicity. Compared with commercial drugs
such as SS and polymer-dispersed AgNP (Poly-Ag), the AgNP/
NSPs were found to show a trend of lower toxicity at
a concentration of 8.75 ppm Ag. (Fig. 1a).
The role of NSP as a support for AgNP in comparison with
organic dispersants was further evaluated with respect to its
influence on genotoxicity. The comet assay [22] examines DNA
damage by revealing a ‘‘comet tail’’ of DNA fragments with
different lengths following electrophoresis. In Fig. 1b, the DNA
damage index of each group was calculated by counting the comet
tails in Chinese hamster ovary (CHO) cells treated with Ag/NSP
and Poly-Ag with silver concentrations of 8.75, 17.5, 35, 52.5, and
70 ppm. [20] By comparison, significantly more comet tails caused
by DNA damage were observed in the poly-Ag group than the
AgNP/NSP group where mainly spherical shapes of intact DNA
were found (P,0.05 at each concentration, Student’s t test).
According to the DNA damage index (the ratio of tails to total
comet bodies), no DNA damage could be detected in cells treated
with AgNP/NSP at concentrations lower than 70 ppm. In
contrast, in the Poly-Ag group, extensive and dose-dependent
damage was observed. The control experiments demonstrated no
mutagenic effects in 3 different genotoxicity tests for NSP itself
[20]. It appears that the platelet-shaped NSPs may immobilize
AgNP and impede the nanoparticle penetration into mammalian
cells and bacteria. The use of the NSP support may help avoid
deposition of detrimental silver in the body.
AgNP/NSPs Promote Healing of Infected Wound in Acute
Burn and Excision Models
Wound healing is a complex process involving inflammation,
formation of granulation tissue, re-epithelization, as well as matrix
formation and remodeling. [23] Infection may further impede the
healing process and result in a non-healing wound. Silver
compounds are generally effective for wound healing. [6,7] The
use of AgNP/NSPs could facilitate the healing process owing to
their antimicrobial properties. The wound injury test in acute burn
and excision models was performed with S. aureus as the infective
pathogen. For the purpose of comparison, we used a silver
concentration of 140 ppm for both Poly-Ag and AgNP/NSPs in
the experiments. The concentration is similar to that of the
commercially available AquacelH (AQ). During the healing
process, wound contraction or reduction of the open wound area
was observed, and the results are shown in Figure 2. In the acute
burn model, the wound area in the Staph+AgNP/NSP group was
significantly more reduced than in any of the other 6 groups and
had significantly smaller wound areas at days 2, 4 and 7 (P,0.05,
Student’s t test, Fig. 2a). AQ or SS treatment also resulted in
significantly smaller wound areas compared with the untreated,
Staph, Staph+NSP, and Staph+Poly-Ag groups at most of the
above time points. However, on day 7 AQ did not show a smaller
area than the Staph+NSP treatment; NSP treatment only showed
significantly better wound healing than the Staph and Staph+Poly-
Ag treatments on days 4 and 7 (P,0.05, Student’s t test). Smaller
wound areas were observed in the Poly-Ag group than in the
untreated and Staph groups at days 4 and 7. The Staph+AgNP/
NSP group showed the best therapeutic effect, revealing a clean
wound surface, improved appearance, and less eschar formation
compared with the other silver compounds tested, including AQ
and SS (Fig. 2c).
In the excision wound model, a piece of full-thickness skin
(1.561.5 cm
2) was excised with sterilized scissors. The bacteria-
implanted Staph group showed a persistent discharge from the
wound base and delay in wound closure. The treatment with
AgNP/NSP significantly improved the wound closure, with
a wound area (563.5 mm
2) less than that in any of the other 6
groups, as indicated in Fig. 2b (P,0.05 at days 5, 7, and 15).
Figure 1. Cytotoxicity toward the human foreskin fibroblast (Hs68) cell line after 12 h of incubation with AgNP/NSP, polymer
dispersed AgNP (Poly-Ag) and silver sulfadiazine (SS) using the MTT assay (a). The values are expressed as the mean 6 SD from 4
independent experiments. DNA damage in Chinese hamster ovary (CHO) cells by the comet assay showed the average lengths of the cell tails after
incubation with different concentrations of AgNP/NSP and Poly-Ag (b). Data are shown as the mean 6 SD (at least 200 cell tails were counted in each
sample). *P,0.05 at each concentration, Student’s t test.
doi:10.1371/journal.pone.0038360.g001
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areas compared with the untreated, Staph, Staph+NSP and
Staph+Poly-Ag groups at days 5, 7 and 15 (P,0.05, Student’s t
test). SS treatment only reached a significant difference compared
with the above 4 groups at day 15. No difference between
Staph+AgNP/NSP, Staph+AQ, and Staph+SS with respect to
wound closure was observed at day 15.
The Effects of AgNP/NSP Treatment on the Cytokine
Levels
During the wound healing process, many factors contribute to
wound closure. This process is executed and regulated by an
equally complex signaling network involving numerous growth
factors. [23] In this study, we chose VEGF-A, TGF-b1, and IL-6
to represent 3 different aspects of the wound healing process, i.e.,
angiogenesis, fibrogenesis, and inflammation.
In the acute burn model, the serum VEGF-A levels were found
to be significantly higher in the Staph+AgNP/NSP group than the
Staph+NSP, Staph+Poly-Ag, and Staph groups (Table 1, P,0.01).
The VEGF-A levels, however, were similar in the Staph+AgNP/
NSP, Staph+AQ, and Staph+SS groups. VEGF-A is an important
growth factor involved in vasculogenesis and angiogenesis. It was
found that AgNP/NSP had the same effect as the commercial
products (AQ and SS) on VEGF levels. TGF-b1 is a protein that
controls the proliferation of keratinocytes at the wound edge and
increases cell number to promote wound covering through re-
epithelization. The results indicated that the serum levels of TGF-
b1 were significantly higher in the Staph+AgNP/NSP group than
the Staph group (P,0.01). The TGF-b1 concentration in the
Figure 2. Wound healing rates on (a) acute burn model (b) excision wound model and the photographs of wound appearance on
day 5 after (c) acute burn injury and (d) excision injury. The rate of infected wound healing was compared in animals treated with
staphylococcus only (Staph), staphylococcus and NSP (Staph+NSP), staphylococcus and Poly-Ag (Staph+Poly-Ag), staphylococcus and AgNP/NSP
(Staph+AgNP/NSP), staphylococcus and AquacelH (Staph+AQ), staphylococcus and silver sulfadiazine (Staph+SS), and control (untreated). The results
are expressed as the mean 6 SD from three independent experiments in each group. *P,0.05, comparison between AgNP/NSP and the other 6
groups at each time point; { P,0.05, comparison between SS treatment with the untreated, Staph, Staph+NSP, and Staph+Poly-Ag groups; { P,0.05,
comparison between AQ treatment with the untreated, Staph, Staph+NSP, and Staph+Poly-Ag groups; # P,0.05, comparison between NSP
treatment with untreated, Staph and Staph+Poly-Ag groups; 1 P,0.05, comparison between Poly-Ag treatment with untreated and Staph groups. All
the comparisons were confirmed by Student’s t test.
doi:10.1371/journal.pone.0038360.g002
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with the commercial products, AQ and SS. IL-6 is a pro-
inflammatory cytokine that is up-regulated in the early in-
flammatory phase. [24] The expression levels of IL-6 in the
Staph+AgNP/NSP group were similar to the levels of IL-6 in the
Staph+AQ and Staph+SS groups. For all three cytokines, AgNP/
NSP had a beneficial effect in the excision wound model, when
compared with the Staph group (Table 1).
We have examined the changes in the cytokine levels of the
local wound tissue by collecting the wound skin and analyzing the
mRNA expression of VEGF-A, TGF-b1, and IL-6 at day 7 (acute
burn wound) and day 15 (excision wound). In accordance with the
circulating levels, in both wound models, the expression of VEGF-
A mRNA in the Staph+AgNP/NSP, Staph+AQ, and Staph+SS
groups were all significantly higher than that in the Staph,
Staph+NSP, and Staph+Poly-Ag groups (P,0.01). A similar trend
was observed for TGF-b1 mRNA expression when comparing
Staph+AgNP/NSP with the other groups in the acute burn wound
model. However, in the excision wound model (Fig. 3b), there was
no significant difference in the levels of TGF-b1 mRNA
expression. The expression of IL-6 mRNA in the local wound
tissue was similar among the six groups in both models.
In conclusion, the newly developed nanohybrid AgNP/NSP
exhibited several functions when applied to the healing of infected
mouse skin wounds. The serum levels and local mRNA expression
of VEGF-A, TGF-b1, and IL-6 in mice treated with the
nanohybrid were similar to those of two conventional silver
compounds, AQ and SS. The presence of the NSP supports for the
AgNPs resulted in a trend of lower cytotoxicity than for Poly-Ag
and SS at 8.75 ppm Ag on fibroblasts and high effectiveness for
wound healing. The combination of nanometer-scaled inorganic
materials, Ag particles, and silicate platelets represents a novel
approach for developing new wound-dressing agents. Further tests
are needed to fully understand the molecular mechanisms of these
nanomaterials during wound healing.
Materials and Methods
Materials
Sodium montmorillonite, a natural smectite aluminosilicate,
was obtained from Nanocor Co. (USA). The clay has a generic
structure of 2/1 layered silicate/aluminum oxides with 2
tetrahedral sheets sandwiching an edge-shared octahedral sheet
and exchangeable Na
+ counter ions with a cation exchange
capacity (CEC) of 120 mequiv/100 g. The NSPs were prepared
from the exfoliation of the sodium form of smectite montmoril-
lonite clay by a polyamine salt, followed by a two-phase extraction
process as described in previous studies. [16] The NSPs possess
a large surface area (720 m
2/g) and intense surface anionic charges
(approximately 18,000 charges/platelet). The copolymer, poly
(styrene-co-maleic anhydride) with styrene/maleic anhydride
molar ratios of 3/1 in the backbones, was purchased from Aldrich
Chemical Co. and designated as SMA3000. The poly (oxyethy-
lene–oxypropylene)-monoamine (POE-amine) with the designated
trade name of JeffamineH M2070 was obtained from Huntsman
Chemical Co. The amine is hydrophilic and water-soluble, and it
has a backbone of oxyethylene/oxypropylene blocks at 32/10 unit
molar ratio with an average molecular weight of 2000. Silver
nitrate (AgNO3; 99.8%) was purchased from SHOWA Chemical
Co.
Preparation of the AgNP/NSP Nanohybrid
NSPs (0.3 g in 30 g of water; 1.0 wt%) were dispersed in
deionized water and mechanically stirred, followed by the addition
of AgNO3 solution (0.061 g of 1.0 wt% in water) at an equal molar
ratio of Ag
+ to CEC. The process involved the replacement of Ag
+
with Na
+ counter ions on the clay surface and the consequent
reduction of Ag
+ by ethanol (18.05 ml). The reaction mixture was
stirred vigorously and monitored by observing the color change
from yellow to deep-red and was analyzed further with UV-vis
spectroscopy and transmission electron microscopy (TEM). It is
possible that the natural clay with a layered structure was
randomized by ionic exchange exfoliation to afford the thin
platelets of NSP. The pristine clay with exchangeable Na
+ counter
ions on the surface was replaced by Ag
+ and subsequently reduced
to stabilized Ag
0 particles. The stably immobilized AgNPs with an
average diameter of 4.9 nm were mostly observed in the platelet
boundary. [21] In our earlier studies, the NSP immobilization for
AgNPs showed the benefit of preventing Ag from aggregation due
to intense van der Waals forces. [25].
Polymer-Ag (Poly-Ag) Colloidal Solution
The aqueous solution of the polymer (1.5 g) and silver nitrate
(0.5 g) was mixed and dissolved in 50 g of deionized water,
Table 1. Cytokine profile of wound healing.
Untreated Staph Staph+NSP Staph+Poly-Ag Staph+AgNP/NSP Staph+AQ Staph+SS
Acute burn model
VEGF-A 744.0627.5* 556.2617.6 517.9632.4 563.5640.1 779.8619.0* 791.4614.7* 777.764.2*
TGF-b1 787.1619.4* 271.7622.7 388.9610.8* 405.166.8* 870.2621.1* 810.6617.2* 878.8617.7*
IL-6 148.5624.1* 547.5615.8 323.3610.5* 278.1612.2* 271.1614.4* 269.3611.8* 281.9611.5*
Excision model
VEGF-A 659.8626.4* 410.1616.1 408.5628.1 575.8618.7* 650.4614.8* 667.7619.8* 599.2632.2*
TGF-b1 419.7630.9* 200.1627.4 225.9631.7 217.8641.8 415.8617.3* 411.8615.3* 423.0640.5*
IL-6 482.6611.4* 799.5614.2 254.9620.1* 233.6617.4* 190.8624.8* 195.0613.9* 197.5613.3*
Serum levels of VEGF-A, TGF-b1 and IL-6 from mice of different treatment groups in both acute thermal injury at day 7 and excision wound at day 15 were examined by
ELISA method.
Results are expressed as the mean (pg/ml) 6 standard deviation (SD) from three independent experiments of each group.
*Statistically significant as compared to the Staph group (P,0.01, Student’s t test).
doi:10.1371/journal.pone.0038360.t001
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water under a nitrogen atmosphere. The solution was stirred at
room temperature for 2–3 h. The formation of polymer-dispersed
AgNP colloidal solution was monitored with a UV-vis spectrom-
eter and TEM. In this work, we selected a conventional polymeric
dispersant for AgNP stabilization and verified the uniqueness of
the NSP effect. The exfoliation of layered clay into NSPs for AgNP
immobilization, and a comparison of Ag particle size between the
NSPs (AgNP/NSP) and the polymeric SMA-M2070 organic
dispersant (Poly-Ag) was performed. A similar particle size of
around 4–5 nm diameter was observed. [20].
Cell Culture and Preparation
Primary human foreskin fibroblasts (Hs68) purchased from the
American Type Culture Collection (Manassas, VA, USA) were
cultured in a complete culture medium composed of Dulbecco’s
modified Eagle’s medium (DMEM), 10% fetal bovine serum,
100 U/ml of penicillin, and 100 U/ml of streptomycin. The cells
were maintained in a humidified atmosphere of 95% air and 5%
CO2 at 37uC. Upon reaching confluence, the cells were
trypsinized with 0.25% trypsin and re-plated onto 10-cm dishes.
Cytotoxicity Assay
The viability of the Hs68 cells was determined using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as-
say (Sigma, USA). [20] The cells were split into 24-well culture
plates at a density of 5610
4 cells/well in l ml of the culture
medium and allowed to attach for 24 h before treatment. After
being replaced by media containing AgNP/NSPs, polymer-
dispersed AgNPs (Poly-Ag), or silver sulfadiazine (SS) (SulfasilH;
Taiwan Veterans Pharmaceutical Co., Ltd., Taoyuan, Taiwan) at
concentrations of 0, 8.75, 17.5, 35, 52.5, and 70 ppm of silver, the
cells were incubated at 37uC under 5% CO2 for 12 h. Then,
MTT solution was added, and the cells were incubated at 37uC for
2 h. The supernatant was removed, and dimethyl sulfoxide
(DMSO) was added to each well to dissolve the formazan crystals.
Then, the soluble solution from each well was transferred to a 96-
well plate. The optical density was measured at 570 nm on an
enzyme-linked immunosorbent assay (ELISA) reader. Absorbance
of the peak height was correlated through a standard curve to the
number of living cells in the culture.
Comet Assay
The procedures for the comet assay were adopted from the
method described by Tice et al. [22] The cells were divided and
cultured in 6-cm culture plates at a density of 5610
5 cells/plate in
2 ml for 24 h. Then, the Ag/NSP and Poly-Ag solutions at
concentrations of 0, 8.75, 17.5, 35, 52.5, and 70 ppm of silver
were added. A negative control (with double-distilled water) and
a positive control (with 100 mMH 2O2 addition) were performed.
After incubation for 24 h at 37uC under 5% CO2, the cells were
trypsinized. The cell suspensions (1610
5 cells/ml; 10 ml) were
mixed with 1% low melting agarose (150 ml) at 37uC and rapidly
spread onto glass slides coated with 1.5% of normal melting point
agarose. The agarose was allowed to solidify by lowering the
temperature to 4uC for 20 min. The cells were lysed by immersing
the slides in a freshly prepared solution (5 M NaCl, 0.5 M EDTA,
1 M Tris-HCl, 1% Triton X-100, 10% DMSO; pH, 10.0) at 4uC
for 40 min. Then the slides were immersed in an alkaline solution
(0.3 M NaOH, 1 mM EDTA; pH, .13) at room temperature.
After 30 min, the slides were placed in a horizontal gel
electrophoresis box containing freshly prepared alkaline electro-
phoresis buffer (0.3 M NaOH, 1 mM EDTA; pH, .13) at 4uC for
30 min before performing electrophoresis. Electrophoresis was
performed at 13 V (1 V/cm) and 300 mA in an ice bath at 4uC
for 20 min. Then, the sample slides were rinsed with double-
distilled water and immersed in 70% ethanol for 5 min. After the
slides were air-dried, 50 ml of diluted propidium iodide (PI)
solution was applied to each circle of dried agarose and covered
with a cover slip. The samples were immediately examined with
a fluorescent microscope. Scores ranging from 0 (undamaged) to 4
(maximally damaged) were estimated according to the tail intensity
(size and shape) for 200 randomly selected cells.
Figure 3. mRNA levels of VEGF-A, TGF-b1 and IL-6 in different treatment groups during wound healing. AgNP/NSP treatment also
modulates the expression of cytokine mRNAs in wounded skin. The levels of VEGF-A, TGF-b1 and IL-6 mRNA expression from mice of different
treatment groups in both acute thermal injury at day 7 (a) and excision wound at day 15 (b) were examined by RT-PCR. Relative band intensities of
different groups were calculated by a densitometer and are demonstrated by the values under the bands. The data shown are representative of three
independent experiments.
doi:10.1371/journal.pone.0038360.g003
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The pathogenic strain of Staphylococcus aureus BCRC 10451 was
purchased from the Bioresource Collection and Research Center
at the Food Industry Research and Development Institute
(Hsinchu, Taiwan), and cultured in nutrient broth medium at
37uC. The bacteria were grown overnight in nutrient broth
(Merck, Darmstadt, Germany), and then, 100 ml of the broth was
inoculated into fresh medium to restart the cell cycle. After 3 h of
incubation at 37uC, the cells were synchronized at the log phase of
the growth curve and grown until they reached an optical density
at 600 nm (OD600) of 0.5–0.6. Then, 1.5 ml aliquots of the
solutions at approximately 1610
8 colony forming unit (CFU)/ml
were applied on the dressings and placed on the wounds.
Animal Experiments
Twelve-week-old male BALB/C mice weighing between 20 and
25 g were purchased from the National Health Research Institute
(Taipei, Taiwan). The animal use protocol in this study was
reviewed and approved by the Institutional Animal Care and Use
Committee (IACUC) of the National Taiwan University College
of Medicine and College of Public Health. The IACUC approval
number is 20080117. All animal work was conducted according to
the national and international guidelines. Anesthesia was achieved
with Zoletil 50 (20–30 mg/kg; Virbac, France) prior to skin
wounding.
The acute burn wound model was performed as described
previously, with modification. [6,19] A burn template was made
from a 60-ml plastic syringe by cutting a window (362c m
2) on the
side with the opposite half removed such that a mouse could be
held horizontally in the burn template. The dorsum of each mouse
was carefully shaved and laid on the burn template after
anesthesia. An iron plate of size 1.561.5 cm
2 was roasted at
180uC and placed onto the exposed dorsal skin of each mouse for
20 s. All the mice were then immediately placed in an ice-water
bath to stop the burning process. This method was used to form
a deep partial-thickness thermal injury. For the excision wound
model, the dorsal hair of each mouse was shaved, and a piece of
full-thickness skin (1.561.5 cm
2) was excised with sterilized
scissors. [6].
In the excision wound and burn models, the mice were divided
into 7 groups: (1) untreated control, (2) Staphylococcus aureus
treatment only (Staph), (3) Staphylococcus aureus and NSP treatment
(Staph+NSP), (4) Staphylococcus aureus and Poly-Ag treatment
(Staph+Poly-Ag), (5) Staphylococcus aureus and AgNP/NSP treat-
ment (Staph+AgNP/NSP), (6) Staphylococcus aureus and AquacelH
treatment (Staph+AQ), (7) Staphylococcus aureus and silver sulfadi-
azine treatment (Staph+SS). For each group, we applied 1.5 ml of
S. aureus (1610
8 CFU/ml) solution to a piece of clean gauze to
produce a ‘‘bacterial dressing’’ that was immediately placed on the
wounds. The wounds were then covered with the ‘‘bacterial
dressings’’ and bandaged for 1 day to let the bacterial solution
enter the wound area. The ‘‘bacterial dressing’’ has little
disinfectant activity as it only consists of a piece of gauze and
contains no medications. One day later, we changed the dressings
to the therapeutic dressings corresponding to the different
treatments. Each treatment was then topically applied to the
wound bed on the second day. The wound dressings were changed
daily until sacrifice. While changing the dressings, a close-up
picture of each wound was taken, and the wound appearance was
inspected by three dermatologists to evaluate the edema, necrosis,
exudation, and eschar formation. The mice were sacrificed
humanely by decapitation on the 7
th day after the injury in the
acute burn wound group or on the 15
th day for the excision wound
group. Tissue samples of the wound were harvested for histological
examination and RNA extraction. Blood samples were also
obtained and immediately transferred into EDTA-coated tubes.
After centrifugation at 3000 g for 15 min, the serum samples were
removed and stored at 270uC.
Preparation of Dressings
In both the Poly-Ag and AgNP/NSP groups, the same amount
of solution containing 2 mg/ml of each silver preparation was
coated on a dressing and applied topically to the wound bed to
maintain the silver content at 140 ppm. In the AQ group,
a commercialized dressing containing 1.2% silver (140 ppm) in an
ionic form (AquacelH) was applied directly to the wound bed. In
the SS group, the mice were treated by the topical application of
1% silver sulfadiazine (95.2 mg) cream (SulfasilH) on a piece of
sterile, non-adherent, absorbent dressing (262c m
2) to give an
equal amount of silver ions released (140 ppm) as the other Ag
treatment groups.
ELISA
Serum levels of vascular endothelial growth factor (VEGF)-A,
interleukin (IL)-6, and transforming growth factor (TGF)-b1 were
measured with cytokine-specific ELISA kits (Endogen, Woburn,
MA, USA). Each measurement was performed according to the
manufacturer’s instructions and repeated in triplicate.
Reverse Transcription Polymerase Chain Reaction
Total RNA extraction from homogenized fresh-skin tissue was
performed with commercial kits (BIOTECX Laboratory Inc.,
Houston, TX, USA). Reverse transcription of the isolated RNA
was performed in a final reaction volume of 20 ml containing 5 mg
of total RNA in Moloney murine leukemia virus (MMLV) RT
buffer (Promega, Madison, WI, USA) consisting of 10 mM
dithiothreitol, deoxynucleoside 59-triphosphates (dNTPs; each at
2.5 mM), 1 mg of (dT) 12–18 primer, and 200 U of MMLV RT.
The reaction mixture was incubated at 37uC for 2 h, and the
reaction was terminated by heating at 70uC for 10 min. One
microliter of the reaction mixture was then amplified by PCR
using the following primers:
Mouse VEGF-A, sense 59-CAGGCTGCTGTAACGATGAA-
39 and antisense 59-AATGCTTTCTCCGCTCTGAA-39.
Mouse TGF-b1, sense 59-TGACGTCACTGGAGTTG-
TACGG-39 and antisense 59-GGTTCATGTCATG-
GATGGTGC-39.
Mouse IL-6, sense 59-GATGCTACCAAACTGGATA-
TAATC-39 and antisense 59-GGTCCTTAGC-
CACTCCTTCTGTG-39.
Mouse b-actin, sense 59-AGCCATGTACGTAGCCATCC-39
and antisense 59-CTCTCAGCTGTGGTGGTGAA-39.
The PCR cycling profile consisted 40 cycles of 45 s at 95uC
(denaturation), 1 min at 58 or 60uC (annealing), 1 min at 72uC
(elongation), and a final 10-min extension at 72uC. The PCR
samples were subjected to electrophoresis in 1% agarose gel, which
was then stained with ethidium bromide and photographed under
UV illumination. Relative band intensities to quantify the mRNA
levels for different tests were calculated by a densitometer.
Statistical Analysis
The two-tailed Student’s t test was used for simple comparison
of 2 values where appropriate. The data from 3 or 4 independent
experiments were expressed as the mean 6 SD. A P-value of less
than 0.05 was considered statistically significant for all the tests. All
analyses were performed with the use of SAS software (version
8.02; SAS Institute, Cary, NC, USA).
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UV-vis spectroscopy of the AgNP solution was performed on
a Shimadzu UV-2450 spectrophotometer.
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